United States · FDA National Drug Code directory
IBUPROFEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11673-991_0e071c42-0f7e-586e-e063-6394a90a9533
- Product NDC
- 11673-991
- Form
- TABLET, COATED
- Composition / generic term
- IBUPROFEN
- Labeler
- TARGET CORPORATION
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200204
- Source listing expiry
- 20261231
Source-listed ingredients
- IBUPROFEN — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, COATED in 1 BOTTLE (11673-991-01) · 11673-991-01
- 50 TABLET, COATED in 1 BOTTLE (11673-991-05) · 11673-991-05
- 200 TABLET, COATED in 1 BOTTLE (11673-991-20) · 11673-991-20
- 500 TABLET, COATED in 1 BOTTLE (11673-991-50) · 11673-991-50
- 1000 TABLET, COATED in 1 BOTTLE (11673-991-88) · 11673-991-88
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →